Literature DB >> 7075609

Hemodynamic and cardiac metabolic effects of inotropic stimulation with dobutamine in patients with coronary artery disease.

W Kupper, D Waller, P Hanrath, W Bleifeld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7075609     DOI： 10.1093/oxfordjournals.eurheartj.a061258

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

Review 1.  Inotropic agents in the treatment of cardiogenic shock.

Authors:  H S Mueller
Journal:  World J Surg       Date:  1985-02       Impact factor: 3.352

2.  Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance.

Authors:  H H Erlemeier; W Kupper; W Bleifeld
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

3.  Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion.

Authors:  G Svenson; L E Strandberg; B Lindvall; L Erhardt
Journal:  Br Heart J       Date:  1988-12

4.  Evaluation of the anti-ischemic effects of D-ribose during dobutamine stress echocardiography: a pilot study.

Authors:  Stephen G Sawada; Stephen Lewis; Roxanne Kovacs; Samer Khouri; Irmina Gradus-Pizlo; John A St Cyr; Harvey Feigenbaum
Journal:  Cardiovasc Ultrasound       Date:  2009-02-07       Impact factor: 2.062
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.